The top male and female from every country with a CrossFit affiliate will receive an invitation to the Games. Can you imagine how difficult it is to win the Open if you’re in a country like USA, Canada, U.K., or Australia? Don’t expect to see many of the big names competing seriously in the Open. They may participate to keep things interesting (and in order to be seeded well for the Games), but I don’t think any of them are doing it expecting to win and have that be their meal ticket.
But eventually — probably on day 33 — I started to experiment. First came eating ketchup ... no side effect. Next, I had some red wine ... a slight hangover the next day, but nothing like I used to experience when indulging in sugary cocktails. Then, I added gluten ... and my body officially freaked out. I broke out in a rash and hives all over my scalp, neck, and legs which lasted for a few days. I decided to try eating gluten again after the rashes went away to make sure, and sure enough, I woke up the next day to ... more rashes.
Let the apples and onions cook down for a bit until they begin to become translucent. When they do, add juice of 1/2 lemon, ½ tsp cinnamon, 1 tsp nutmeg, salt, pepper, 1/2 tsp garlic powder, and 1/2 tsp onion powder and mix thoroughly to help combine and let caramelize. Turn the heat down a notch or two and continue to cook down, stirring occasionally.
After the Internet fitness community began talking about an Ohio State University study that described relatively high injury rates among CrossFitters, the Russes mobilized. They had Glassman's father, Jeffrey Glassman (now "chief scientist" at CrossFit), write a comprehensive rebuttal to the study for the CrossFit website. Berger called each and every research subject who had been reported as injured, to conclude that none actually were hurt, and then added an entire stammering Q&A with one of the paper's authors, kinesiology professor Steven Devor. Here's the kicker: The actual subject of the study was the great improvements in fitness the researchers found in CrossFit athletes. Aside from a handful of sentences, it was all positive.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”